# FDA Inspection 1202927 - Octapharma Plasma Inc - April 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b989d6a1-86f2-4ac8-8208-1b54145c0574
Source feed: FDA_Inspections

> FDA Inspection 1202927 for Octapharma Plasma Inc on April 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202927
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-04-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1202927 - 2023-04-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6b1887fe-32c7-49ed-9e5b-f896bc25b5a2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1634ab19-cb2d-4656-a7bf-f6da12cc9d4d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d